- Home
- / Helix BioPharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Helix BioPharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.9
2024-10-29
Market Capitalization
$44.1 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 305.0K | |||||||
| Operating expense total | 8.4M | 7.4M | 8.4M | 9.0M | 5.9M | 6.2M | 9.0M | 5.4M |
| Depreciation and amortization | 167.0K | 126.0K | 212.0K | 173.0K | 12.0K | 13.0K | 14.0K | 10.0K |
| EBITDA | (8.4M) | (7.4M) | (8.4M) | (9.0M) | (5.9M) | (6.2M) | (9.0M) | (5.1M) |
| EBIT | (8.5M) | (7.5M) | (8.6M) | (9.6M) | (6.4M) | (6.2M) | (9.0M) | (5.1M) |
| Interest income | 9.0K | 3.0K | 25.0K | 4.0K | 47.0K | 31.0K | 17.0K | |
| Interest expense | 29.0K | 1.0K | 25.0K | 15.0K | 18.0K | 14.0K | 7.0K | 10.0K |
| Pre tax profit | (8.6M) | (7.5M) | (8.6M) | (9.6M) | (6.6M) | (6.3M) | (9.3M) | (5.2M) |
| Net Income | (8.6M) | (7.5M) | (8.6M) | (9.6M) | (6.6M) | (6.3M) | (9.3M) | (5.2M) |